Neisseria meningitidis and meningococcal disease: recent discoveries and innovations

Area of Science:

• Microbiology
• Epidemiology
• Vaccinology

Background:

• Meningococcal disease, caused by Neisseria meningitidis, presents a significant public health threat due to the emergence of virulent, rapidly spreading clones.
• The pathogen's ability to acquire new genetic material facilitates the emergence of novel strains capable of causing severe outbreaks.

Purpose of the Study:

• To review recent advancements in understanding and combating meningococcal disease, focusing on population biology, vaccine development, and prevention strategies.
• To highlight the challenges posed by evolving meningococcal strains and the need for continuous surveillance.

Main Methods:

• Review of recent findings on meningococcal population biology, including the emergence of specific clonal complexes.
• Analysis of the efficacy and limitations of current vaccination strategies (glycoconjugate and protein-based vaccines) against various serogroups.
• Evaluation of mass chemoprophylaxis as an alternative or supplementary prevention method.

Main Results:

• Recent virulent Neisseria meningitidis strains, particularly from clonal complex 11, have emerged, expressing serogroups C and W, leading to severe disease globally.
• Glycoconjugate vaccines (ACWY, ACWYX) are effective against targeted serogroups, while newer outer membrane protein-based vaccines for NmB are immunogenic but may not reduce carriage effectively.
• Mass chemoprophylaxis shows promise but faces sustainability challenges.

Conclusions:

• Despite significant progress, the genomic adaptability of Neisseria meningitidis necessitates ongoing surveillance to detect and respond to emerging clones with potential vaccine resistance.
• Sustainable prevention relies on a multifaceted approach, including highly immunogenic vaccines and potentially novel strategies to reduce pathogen carriage and transmission.